The epidemiology of cardiovascular diseases in sub-saharan Africa: The global burden of diseases, injuries and risk factors 2010 study

Progress in Cardiovascular Diseases

Volumn 56, Issue 3, 2013, Pages 234-239

  Moran, Andrew ^a   Forouzanfar, Mohammad ^b   Sampson, Uchechukwu ^c   Chugh, Sumeet ^d   Feigin, Valery ^e   Mensah, George ^f  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Burden of disease; Cardiovascular disease; Global health; Mortality; Sub Saharan Africa

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; EPIDEMIOLOGICAL DATA; HEART ATRIUM FIBRILLATION; HUMAN; INJURY; LIFE EXPECTANCY; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; SOUTH AFRICA; URBANIZATION;

BURDEN OF DISEASE; CARDIOVASCULAR DISEASE; CVD; GBD 2010; GLOBAL BURDEN OF DISEASE 2010 STUDY; GLOBAL HEALTH; ICD; INTERNATIONAL CLASSIFICATION OF DISEASES; MORTALITY; SUB-SAHARAN AFRICA; YEARS LIVED WITH DISABILITY; YEARS OF LIFE LOST DUE TO DISABILITY; YLD; YLL;

AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84888000068     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2013.09.019     Document Type: Article

References (25)

1. Mensah G.A. Ischaemic heart disease in Africa. Heart 2008, 94(7):836-843.
2. Bradshaw D., Timaeus I.M. Levels and trends of adult mortality. Disease and mortality in Sub-Saharan Africa 2006, World Bank, PMID: 21290658, Washington (DC). 2nd ed. D.T. Jamison, R.G. Feachem, M.W. Makgoba (Eds.).
3. Murray C.J., Vos T., Lozano R., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
4. Murray C.J., Ezzati M., Flaxman A.D., et al. GBD 2010: design, definitions, and metrics. Lancet 2012, 380(9859):2063-2066.
5. Lozano R., Naghavi M., Foreman K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2095-2128.
6. Vos T., Flaxman A.D., Naghavi M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2163-2196.
7. Salomon J.A., Vos T., Hogan D.R., et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2129-2143.
8. Forouzanfar M.H., Moran A.E., Flaxman A.D., et al. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart 2012, 7(4):331-342.
9. Damasceno A., Mayosi B.M., Sani M., et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012, 172(18):1386-1394.
10. Walker R., Whiting D., Unwin N., et al. Stroke incidence in rural and urban Tanzania: a prospective, community-based study. Lancet Neurol 2010, 9(8):786-792.
11. Sliwa K., Wilkinson D., Hansen C., et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008, 371(9616):915-922.
12. Ntsekhe M., Damasceno A. Recent advances in the epidemiology, outcome, and prevention of myocardial infarction and stroke in sub-Saharan Africa. Heart 2013, 99(17):1230-1235.
13. Dalal S., Beunza J.J., Volmink J., et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 2011, 40(4):885-901.
14. Feigin V.L., Lawes C.M., Bennett D.A., Barker-Collo S.L., Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8(4):355-369.
15. Gersh B.J., Sliwa K., Mayosi B.M., Yusuf S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 2010, 31(6):642-648.
16. Chugh S. The global burden of cardiac arrhythmias 2013, Under Review, Circulation.
17. Fowkes F.G., Rudan D., Rudan I., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013, [Epub ahead of print]. http://dx.doi.org/10.1016/S0140-6736(13)61249-0.
18. Pobee J.O. Study of cardiovascular diseases in developing countries supported by the World Health Organization. Experience in Ghana 1972-1982. Cas Lek Cesk 1986, 125(10):289-292.
19. Commerford P., Ntsekhe M. Ischaemic heart disease in Africa. How common is it? Will it become more common?. Heart 2008, 94(7):824-825.
20. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 2008, 118(25):2725-2729.
21. Khatibzadeh S., Farzadfar F., Oliver J., Ezzati M., Moran A. Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol 2013, 168(2):1186-1194.
22. Sliwa K., Mayosi B.M. Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart 2013, 99(18):1317-1322.
23. Ntusi N.B., Mayosi B.M. Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther 2009, 7(2):169-180.
24. Bloomfield G.S., Barasa F.A., Doll J.A., Velazquez E.J. Heart failure in sub-saharan Africa. Curr Cardiol Rev 2013, 9(2):157-173.
25. Cooper R.S., Osotimehin B., Kaufman J.S., Forrester T. Disease burden in sub-Saharan Africa: what should we conclude in the absence of data?. Lancet 1998, 351(9097):208-210.